《Science,5月15日,Structure of the RNA-dependent RNA polymerase from COVID-19 virus》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-05-16
  • Structure of the RNA-dependent RNA polymerase from COVID-19 virus

    Yan Gao1,2,*, Liming Yan1,*, Yucen Huang1,*, Fengjiang Liu2,*, Yao Zhao2, Lin Cao3, Tao Wang1, Qianqian Sun2, Zhenhua Ming4, Lianqi Zhang1, Ji Ge1, Litao Zheng1, Ying Zhang1, Haofeng Wang2,5, Yan Zhu2, Chen Zhu2, Tianyu Hu2, Tian Hua2, Bing Zhang2, Xiuna Yang2, Jun Li2, Haitao Yang2, Zhijie Liu2, Wenqing Xu2, Luke W. Guddat6, Quan Wang2,†, Zhiyong Lou1,†, Zihe Rao1,2,3,7,†

    See all authors and affiliations

    Science 15 May 2020:

    Vol. 368, Issue 6492, pp. 779-782

    DOI: 10.1126/science.abb7498

    Abstract

    A novel coronavirus [severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2)] outbreak has caused a global coronavirus disease 2019 (COVID-19) pandemic, resulting in tens of thousands of infections and thousands of deaths worldwide. The RNA-dependent RNA polymerase [(RdRp), also named nsp12] is the central component of coronaviral replication and transcription machinery, and it appears to be a primary target for the antiviral drug remdesivir. We report the cryo–electron microscopy structure of COVID-19 virus full-length nsp12 in complex with cofactors nsp7 and nsp8 at 2.9-angstrom resolution. In addition to the conserved architecture of the polymerase core of the viral polymerase family, nsp12 possesses a newly identified β-hairpin domain at its N terminus. A comparative analysis model shows how remdesivir binds to this polymerase. The structure provides a basis for the design of new antiviral therapeutics that target viral RdRp.

  • 原文来源:https://science.sciencemag.org/content/368/6492/779
相关报告
  • 《5月15日_COVID-19病毒RNA依赖的RNA聚合酶的结构》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-05-16
    • 信息名称:COVID-19病毒RNA依赖的RNA聚合酶的结构 1.时间:2020年5月15日 2.机构或团队:清华大学、上海科技大学、南开大学、天津大学、昆士兰大学、中国科学院生物物理研究所 3.事件概要: 清华大学联合多家机构在Science发表论文“Structure of the RNA-dependent RNA polymerase from COVID-19 virus”。 文章重点研究了在病毒复制和转录周期中起关键作用的复合物,他们使用低温电子显微镜来确定RNA依赖的RNA聚合酶nsp12的2.9埃分辨率的结构,该酶与两个辅助因子nsp7和nsp8结合,催化病毒RNA的合成。nsp12是核苷类抗病毒抑制剂如瑞德西韦的靶点,其结构可能为设计新的抗病毒药物提供基础。 4.附件: 原文链接:https://science.sciencemag.org/content/368/6492/779
  • 《MJAFI,5月30日,Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-05-31
    • Evaluating the potential of different inhibitors on RNA-dependent RNA polymerase of severe acute respiratory syndrome coronavirus 2: A molecular modeling approach Author links open overlay panelShuvasishChoudhuryaDebojyotiMoulickbPurbajyotiSaikiacMuhammed KhairujjamanMazumderc Show more https://doi.org/10.1016/j.mjafi.2020.05.005 Abstract Background Coronavirus disease 2019 (COVID-19) has already affected 2883603 and killed 198842 people, as of April 27, 2020. Because there is no specific therapeutic drug, drug repurposing has been proposed. RNA-dependent RNA polymerase (RdRp) is a promising drug against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to control its replication, and several compounds have been suggested. The present study predicts relative efficacies of thirty known or repurposed compounds in inhibiting the RdRp. Methods The three-dimensional structure of the target enzyme was loaded into Molegro virtual docker software, followed by chemical structures of the test compounds. The docking was performed between the compounds and the active site of the enzyme to determine docking scores, and the energy liberated when the two dock. Thus, docking scores signify the affinity of ligand(s) with the active site of enzyme(s) and thus its inhibitory potential.